This study is testing a device called Transcutaneous Electrical Nerve Stimulation (tVNS) for people with paroxysmal atrial fibrillation (AF), which is an irregular heartbeat that comes and goes. The researchers want to see how tVNS, which uses low-level electrical stimulation on the outer ear, affects AF over six months. They are also looking for signs in the body that show who might respond best to this treatment. You may be able to join if you are between 21 and 90 years old and have paroxysmal AF. The study is looking for 160 participants, but the current recruitment status is unclear.

Study design

This interventional study involves randomizing participants to different stimulation frequencies and intensities to find the optimal settings for tVNS. A subgroup of participants undergoing AF ablation will also be randomized to active or sham tVNS.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint measures the effects of tVNS on Atrial Fibrillation burden at 6 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.